Pharmacy News

NIH: Methamphetamine-involved overdose deaths nearly tripled between 2015 and 2019

A study conducted by the National Institute on Drug Abuse (NIDA) found that overdose deaths in the United States involving methamphetamine nearly tripled from 2015 to 2019 among people 18 to 64 years of age.

Non-Hispanic Black and Mexican-American adults diagnosed with diabetes at a younger age

New findings published in JAMA Network revealed that non-Hispanic Black and Mexican-American adults were diagnosed with diabetes at a younger age—typically 4 to 7 years earlier—than non-Hispanic whites.

North Dakota, which once lost its fight to regulate PBM practices, gets a rematch

At the U.S. Eighth Circuit Court of Appeals last week, Pharmaceutical Care Management Association (PCMA) and North Dakota delivered oral arguments in litigation over state laws regulating some PBM practices. The proceedings were the latest step in PCMA v Wehbi’s winding path through the courts. The circuit court once sided with the PBM lobbying group, but the U.S. Supreme Court vacated that ruling after it unanimously decided to uphold an Arkansas PBM-regulation law.

Tocilizumab in short supply due to pandemic

Some individuals with rheumatoid arthritis (RA) are treated with a monthly infusion of the biologic tocilizumab (Actemra—Genentech). However, the drug is now in short supply because of the surge in COVID-19 cases.

CDC releases guidance on caring for ‘COVID long-haulers’

Thousands of patients have reported experiencing a wide range of physical and mental health consequences that persist after a COVID-19 infection. Patients with post-COVID-19 conditions, sometimes referred to as “COVID long-haulers,” often experience issues four or more weeks after being infected with the virus. Many of these patients routinely seek medical treatment for relief of their symptoms.

RSS

First Previous 36 37 38 39 40 41 42 43 44 45 Next